Eupraxia Pharmaceuticals Announces CFO Succession
Bruce Cousins is retiring, and former CFO Alex Rothwell will assume the role Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology company, today announced that it has appointed Alex Rothwell as the Company's new Chief Financial Officer, effective immediately. https://mma.prnewswire.com/media/2621903/Eupraxia_Pharmaceuticals_Inc__Eupraxia_Pharmaceuticals_Announces.jpg Bruce Cousins, the Company's outgoing CFO, is retiring and […]